67 results
8-K
EX-99.1
ALEC
Alector Inc
8 May 24
Alector Reports First Quarter 2024 Financial Results
4:10pm
. Forward-looking statements in this press release include, but are not limited to, statements regarding our business plans, business strategy, product
8-K
EX-99.1
ALEC
Alector Inc
27 Feb 24
Alector Reports Fourth Quarter and Full Year 2023 Financial Results
4:10pm
-Neurology Therapeutic Approach.” The publication discusses immuno-neurology as an emerging therapeutic strategy for dementia and neurodegeneration … by the Company’s strategy to prioritize late-stage programs.
G&A Expenses. Total general and administrative expenses for the quarter ended December 31
424B5
r8osonmexuf3ivwg
19 Jan 24
Prospectus supplement for primary offering
6:04am
424B5
zkr 9ziehn
16 Jan 24
Prospectus supplement for primary offering
4:02pm
424B5
mut5wym0 adzf60euq8h
7 Nov 23
Prospectus supplement for primary offering
5:02pm
8-K
EX-99.1
aunswk57g 7uc
7 Nov 23
Alector Reports Third Quarter 2023 Financial Results and Provides Business Update
4:10pm
8-K
EX-99.1
hs71j97te4a o2pq9p1z
3 Aug 23
Alector Reports Second Quarter 2023 Financial Results and Provides Business Update
4:11pm
8-K
EX-99.1
u1anhxunvk
4 May 23
Alector Reports First Quarter 2023 Financial Results and Provides Business Update
4:10pm
8-K
dmqj8ft
29 Mar 23
Cost Associated with Exit or Disposal Activities
4:06pm
8-K
EX-99.1
9du1xvum
8 Nov 22
Alector Reports Third Quarter 2022 Financial Results and Provides Business Update
4:10pm
8-K
EX-99.1
zedxefwuuxvo3j62ech
4 Aug 22
Alector Reports Second Quarter 2022 Financial Results and Provides Business Update
4:33pm